Skip to main content

Table 1 Unadjusted correlates of dose 3 completion

From: Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities

 

N*

uOR

95% CI

p-value

Accelerated treatment group

595

1.61

1.16

2.24

0.01

City

595

    

  Chicago

 

Reference

   

  Hartford

 

0.75

0.46

1.22

0.25

  Bridgeport

0.48

0.24

0.93

0.03

Race

588

    

  Non-Hispanic Black/African American

 

Reference

   

  White

 

0.74

0.49

1.13

0.15

  Hispanic

 

0.63

0.43

0.94

0.02

  Excluded Native American/Alaskan Native, Other, Refused (n = 7)

  

Women

594

1.45

1.00

2.11

0.05

Age (continuous, range 18–68)

595

1.05

1.03

1.07

<.01

Education

581

    

  Less Than high school

Reference

   

  High school or graduate equivalency degree

 

0.94

0.63

1.39

0.74

  Some College or College graduate

1.15

0.76

1.75

0.51

  Excluded missing other (14) and vocation schools (11)

   

Employment (Full- or part-time)

578

0.66

0.44

1.01

0.05

Average monthly income

    

  $0-300

 

Reference

   

  $301-556

 

0.87

0.52

1.45

0.58

  $557-1,000

1.10

0.70

1.73

0.68

  $1,001-9,000

0.76

0.47

1.23

0.26

Not homeless

577

0.93

0.66

1.31

0.68

Excluded missing (n = 14), and don’t know (n = 4)

    

Pay for housing

582

1.43

1.03

1.99

0.04

Self-reported health status (Likert 1 = excellent, 5 = poor)

578

1.21

1.02

1.42

0.03

Excluded missing (13) and don’t know (4)

     

Told by health care worker HCV pos

576

0.97

0.59

1.60

0.90

Excluded missing (15) and don’t know/unsure (4)

     

Doctors visit during past year

582

1.06

0.74

1.51

0.80

Customer of local syringe exchange

539

0.98

0.64

1.49

0.91

Main source of syringes, prior 30 days

558

    

  SEP direct

 

Reference

   

  Pharmacy

 

0.45

0.19

1.05

0.06

  SEP customer

 

0.37

0.22

0.64

<0.01

  Diabetic, someone else, at place you shoot

 

0.79

0.47

1.34

0.38

Excluded missing (37)

     

Most syringes from this exchange, past 3 months

462

1.59

1.07

2.37

0.02

EVER referred by SEP to healthcare/drug tx/social service

575

1.29

0.28

2.00

0.26

Excluded missing (17) don’t know (3)

     

Average # of shots from a syringe (range 1–75)

557

0.98

0.93

1.02

0.31

Total injections, prior 30 days (range 1–540)

521

1.00

0.99

1.00

0.84

Excluded does not apply (n = 25)

     

Used a needle someone else had used at least, prior 30 days

553

1.73

0.90

3.33

0.10

Someone paid you w/ drugs or money for sex

580

1.21

0.81

1.80

0.36

You paid someone with drugs or money for sex

575

0.83

0.55

1.25

0.38

Language of interview

582

    

  English

 

Reference

   

  Spanish

 

0.57

0.30

1.10

0.09

Language spoken most often

578

    

  English

 

Reference

   

  Spanish

 

0.76

0.45

1.27

0.30

  Excluded missing and other (n = 3)

     

Hepatitis Knowledge

585

2.78

0.45

17.10

0.27

Vulnerability

581

1.01

0.85

1.19

0.94

Severity

581

1.10

0.93

1.30

0.25

Response efficacy

580

1.01

0.85

1.19

0.94

Self-efficacy

581

0.93

0.79

1.10

0.39

Social outcome expectancy

580

1.04

0.88

1.23

0.64

Social outcome value

581

1.05

0.89

1.24

0.57

  1. *The number of people answering each question is included, numbers may not equal 595 due to missing data.
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us